Genomic Freedom in Court | GenomeWeb

The US Supreme Court case concerning Myriad Genetics' patent claims on BRCA 1 and BRCA 2 is an important battle in a fight for freedom — genomic freedom — and those claims just represent "the tip of the iceberg," Chris Mason argues in the Huffington Post.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.